Epitalon is a synthetic chain of four amino acids, developed in Russia from an animal brain-gland extract and marketed to influence biological aging, mainly as an injectable research product. No benefit reaches high or medium confidence: human data are small and come mainly from its developers, while lifespan and tumor findings come from animals and cultured cells. Reported risks are mostly theoretical or concern product quality. (Full Review)
| Marker | Target | Why |
|---|---|---|
| Fasting glucose | 75–90 mg/dL | Glucose handling changed in aged monkeys |
| HbA1c | 4.6–5.3% | Three-month glucose average |
| Fasting insulin | 2–6 µIU/mL | Insulin response normalized in old monkeys |
| Complete blood count with differential | White cells 4.5–7.0 ×10³/µL, no abnormal differential | Immune effects seen in animals |
| hs-CRP | Under 1.0 mg/L | General inflammation marker |
| Night melatonin (saliva or urinary 6-sulfatoxymelatonin) | No established target; track change from own baseline | The main marker reported to shift |
| Blood telomere length (optional) | No established target; track change from own baseline | The intended target of telomerase claims |
Cadence: Baseline before a first course; glucose regulation markers, blood counts, and inflammation markers at the end of each course (about 2–4 weeks after starting), again at 3 months, then every 6–12 months; night melatonin 2–4 weeks after a course; telomere length no more often than every 12 months in the same laboratory